Drug Shortage Report for COLISTIMETHATE FOR INJECTION, USP
| Report ID | 257464 |
| Drug Identification Number | 02403544 |
| Brand name | COLISTIMETHATE FOR INJECTION, USP |
| Common or Proper name | COLISTIMETHATE FOR INJECTION, USP |
| Company Name | FRESENIUS KABI CANADA LTD |
| Market Status | MARKETED |
| Active Ingredient(s) | COLISTIN |
| Strength(s) | 150MG |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR |
| Packaging size | 6.5 mL |
| ATC code | J01XB |
| ATC description | OTHER ANTIBACTERIALS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2025-06-01 |
| Actual start date | |
| Estimated end date | 2025-07-10 |
| Actual end date | 2025-07-10 |
| Shortage status | Resolved |
| Updated date | 2025-07-11 |
| Company comments | Fresenius Kabi Canada regrets to advise that due to shipping delays, we will be extending the backorder on our Colistimethate for Injection, USP 150 mg, Vial until July 10, 2025. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v8 | 2025-07-11 | English | Compare |
| v7 | 2025-07-09 | French | Compare |
| v6 | 2025-07-09 | English | Compare |
| v5 | 2025-06-23 | French | Compare |
| v4 | 2025-06-23 | English | Compare |
| v3 | 2025-06-02 | English | Compare |
| v2 | 2025-05-15 | French | Compare |
| v1 | 2025-05-15 | English | Compare |
Showing 1 to 8 of 8